Centro de Oncologia Especializada

What Centro de Oncologia Especializada does

Centro de Oncologia Especializada (COE | Oncologia e Doenças Autoimunes) is a regional Brazilian multi-specialty healthcare provider headquartered in São José dos Campos, São Paulo. Founded in March 1992 in Jacareí as INCON (Instituto de Cirurgia e Oncologia), the group operates three accredited clinics across the Vale do Paraíba region — São José dos Campos, Jacareí, and Taubaté — delivering clinical and surgical oncology across breast, gynecological, head and neck, lung, gastrointestinal, urological, melanoma, sarcoma/CNS, and onco-genetics indications, plus treatment for autoimmune diseases (lupus, Crohn's disease, psoriasis, rheumatoid arthritis, multiple sclerosis) via biological infusions. The company serves private patients covered by health insurance plans, SUS public patients via the Hospital Pio XII partnership where COE is the largest oncology reference in the region, and a B2B corporate health program.

The product surface extends beyond core oncology and autoimmune care to include Rede Carinho (a patient navigation service combining an electronic data platform with Navigator Nurses coordinating rapid diagnosis and treatment initiation), the Instituto de Ensino e Pesquisa (IEP) for clinical research and medical education, the Núcleo de Cuidado Integral (specialized nutrition, psychological support, and integrative medicine), Cuidados Paliativos (palliative care), and Oncologia Preventiva (preventive screening and risk assessment). All three units hold ONA Level 3 - Acreditação com Excelência, the highest Brazilian healthcare quality accreditation, and the group maintains LGPD-compliant data practices under CARINHO HOLDING LTDA (CNPJ 19.399.471/0001-42). A strategic alliance with A.C. Camargo Cancer Center, ONCOH national network membership, and partnerships with Instituto do Câncer Brasil and pharmaceutical sponsors (GSK, Abbvie, Daiichi Sankyo, AstraZeneca, UCB) reinforce clinical and reputational standing.

Revenue is generated primarily through fee-for-service reimbursements from approximately 16+ health insurance partners (Bradesco Saúde, SulAmérica, Porto Seguro, Unimed, Saúde Petrobras, among others), supplemented by SUS public healthcare reimbursements via Hospital Pio XII and a B2B Saúde Corporativa program provided free to empresas with services billed through employee insurance plans. The legal parent is Grupo Carinho, a diversified healthcare conglomerate controlled by founder Dr. Celso Abrahão. The group remains private with no disclosed funding rounds or institutional investors, and growth has been organic — expanding by clinic (2016 Caraguatatuba, 2018 São José dos Campos, 2023 Taubaté) and by service line (2021 autoimmune pivot, 2022 unified branding, 2023 ONA Level 3, ongoing A.C. Camargo alliance).

Name

Centro de Oncologia Especializada

Legal name

CARINHO HOLDING LTDA

Website

https://coe.com.br

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

51–100 employees

Short description

Centro de Oncologia Especializada (COE) is a Brazilian regional healthcare group operating three accredited oncology and autoimmune disease clinics across Vale do Paraíba, serving private insurance patients, SUS public patients via Hospital Pio XII, and corporate clients.

Ownership category

akta.pro rank

Product category

Oncology and Autoimmune Disease Treatment Services

NAICS

Offices of Physicians (62111), Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Ambulatory Specialty Clinics (Multi-Specialty & Single-Specialty) (HLAFABAA), Oncology & Cancer Specialty Hospitals (HLAFAHAC)

Keywords

• Oncology treatment services
• Autoimmune disease care
• Clinical and surgical oncology
• Patient navigation services
• Palliative cancer care

Headquarters

HQ city

São José Dos Campos

HQ country

Brazil

HQ region

Latin America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Healthcare Services - Health Insurance: Revenue generated from services provided to patients covered by health insurance plans (convênios). COE accepts multiple insurance providers including Bradesco Saúde, SulAmérica, Porto Seguro, Unimed, Saúde Petrobras, and others.
2. SUS Oncology Services: Public healthcare services through Hospital Pio XII, which is the largest SUS oncology reference in the Vale do Paraíba region.
3. Corporate Health Program: Free corporate health program for empresas focused on preventive oncology, with services covered by employee health insurance plans.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Core offering

Centro de Oncologia Especializada (COE) operates multi-specialty healthcare clinics providing diagnosis and treatment for oncology (clinical and surgical) and autoimmune diseases. It serves patients across three locations in the Vale do Paraíba region of Brazil (São José dos Campos, Jacareí, and Taubaté), offering personalized multidisciplinary care including chemotherapy, immunotherapy, biological infusions, surgical oncology, palliative care, and patient navigation through its Rede Carinho program.

Product overview

COE | Oncologia e Doenças Autoimunes is a multi-specialty healthcare center offering integrated oncology and autoimmune disease treatment services. The core offerings include clinical and surgical oncology for multiple cancer types (breast, gynecological, head/neck, lung, gastrointestinal, urology, melanoma, sarcoma/CNS, and onco-genetics), along with autoimmune disease treatment including biological infusion therapy. Supporting services include Rede Carinho (patient navigation), Instituto de Ensino e Pesquisa (clinical research and education), Saúde Corporativa (corporate health programs), Núcleo de Cuidado Integral (integrative nutrition, psychology, and integrative medicine), Cuidados Paliativos (palliative care), and Oncologia Preventiva (preventive screening). The Navigator Nurse program coordinates patient care across all services.

Differentiator

Problem solved

Functional benefit

Products and services

• Oncologia Clínica e Cirúrgica
• Tratamento de Doenças Autoimunes
• Rede Carinho (Patient Navigation Service)
• Instituto de Ensino e Pesquisa (IEP)
• Saúde Corporativa (Corporate Health Program)
• Núcleo de Cuidado Integral
• Cuidados Paliativos (Palliative Care)
• Oncologia Preventiva (Preventive Oncology)

Quantifiable outcome

• Rapid treatment initiation through nurse navigator coordination
• +1 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Five partnerships are on record, tiered minor, major and core.

• Pharmaceutical Sponsors (GSK, Abbvie, GSK, Daiichi Sankyo, AstraZeneca)minorGTM or Marketing Partner · 8 April 2026Pharmaceutical companies sponsor COE's educational symposiums and events, including AstraZeneca, Abbvie, GSK, and Daiichi Sankyo for Oncogynecology symposium; GSK, Abbvie, and UCB for Autoimmune Diseases symposium.
• Instituto do Câncer Brasil (ICB)majorStrategic or Co-development Partner · 29 November 2025Partnership with ICB for scientific events including the Simpósio Autoimunes (Autoimmune Diseases Symposium) and other educational programs for healthcare professionals.
• ONCOH - Organização Nacional de Centros de Oncologia e HematologiacoreStrategic or Co-development PartnerCOE is part of ONCOH, a national organization of oncology and hematology centers. Dr. Celso Abrahão serves as Vice President of ONCOH, connecting COE to a broader network of cancer care institutions.
• A.C. Camargo Câncer CentercoreStrategic or Co-development PartnerStrategic alliance with A.C. Camargo Câncer Center, the largest cancer center in Latin America. COE maintains connections for knowledge exchange, training, and quality standards.
• Hospital Pio XIIcoreStrategic or Co-development PartnerCOE provides oncology clinical services at Hospital Pio XII, which serves as the largest SUS (public healthcare) oncology reference in the Vale do Paraíba region.

Scale indicators4 records

Recent moves12 records

Expansion highlights6 records

Direct peers

• A.C. Camargo Cancer Center: The largest cancer center in Latin America, headquartered in São Paulo. A.C. Camargo is COE's direct strategic alliance partner and serves a comparable oncology patient population with similar multidisciplinary clinical and surgical oncology services, including teaching and research.
• Oncoclínicas (Grupo Oncoclínicas do Brasil): Brazil's largest oncology clinic chain, operating multi-specialty oncology centers across the country. Closely comparable to COE in clinical and surgical oncology delivery, multidisciplinary care models, and convênio + SUS revenue mix.
• Hospital de Câncer de Barretos: A flagship oncology hospital in Brazil offering comprehensive cancer diagnosis, treatment, and research. Comparable to COE as a specialty oncology provider focused on clinical, surgical, and preventive oncology with SUS and private care lines.
• Grupo Oncologia D'Or: Brazilian oncology network tied to Rede D'Or, providing outpatient oncology, chemotherapy, and multidisciplinary cancer care across multiple sites. Comparable to COE in operating clinic-format oncology with payer-mix reliance and a multi-unit model.
• Hospital de Amor (Hospital de Câncer de Barretos - network): Network of cancer hospitals in Brazil (formerly Hospital de Câncer de Barretos) offering comprehensive oncology and SUS services. Comparable to COE in regional specialty oncology delivery, multidisciplinary care, and serving both private and public-system patients.

Broad incumbents

• Hospital Israelita Albert Einstein: One of Latin America's leading private hospital systems, with strong oncology and autoimmune disease programs. Comparable to COE for complex oncology and infusion therapy cases, but operates as a broader multi-specialty academic medical center rather than a regional oncology specialist.
• Hospital Beneficência Portuguesa de São Paulo: Major São Paulo private hospital with oncology and specialty infusion services. Comparable to COE in delivering complex clinical and surgical oncology for privately insured patients, but with a broader multi-specialty footprint.
• Hospital Sírio-Libanês: Premier São Paulo-based private hospital with a well-developed oncology center offering clinical oncology, hematology, and infusion services. Comparable as a premium-tier cancer-care provider, but with a broader general hospital portfolio than COE.

Emerging players

• Instituto do Câncer Brasil (ICB): Brazilian oncology organization partnering with COE on autoimmune and gynecologic oncology education and symposia. Comparable as a thematic peer in oncology and autoimmune-disease education, research, and clinical event sponsorship in Brazil.

Regional players

• Instituto do Câncer do Estado de São Paulo (ICESP): Public oncology reference center linked to FMUSP in São Paulo, focused on SUS oncology. Comparable to COE's Hospital Pio XII/SUS oncology operation in serving complex oncology cases, but geographically anchored in São Paulo city rather than Vale do Paraíba.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@coeoncologiaedoencasautoimunes
• Facebookfacebook.com/coe.oncologia
• LinkedInlinkedin.com/company/coe-oncologia-e-doencas-autoimunes
• Instagraminstagram.com/coeoncoimuno

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centro de Oncologia Especializada